The plaintiff alleged that Pfizer illegally barred whites and Asians from applying for its Breakthrough Fellowship Program.

Pfizer settled a lawsuit challenging its diversity fellowship program that allegedly discriminated against white and Asian-American applicants. The resolution follows a 2022 lawsuit from advocacy ...

Quality, high-yield dividend stocks can deliver dependable passive income to help retirees offset inflation. These five make ...

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in ...

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...

Pfizer has resolved a lawsuit with a conservative group challenging its fellowship program aimed at increasing diversity, ...

Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to boost the pipeline of Black, Latino and Native American people in ...

Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...